Skip to content
Tuesday, June 28, 2022
Latest:
  • Research opens the door to improved treatments for congenital heart disease
  • A potentially more effective treatment for HER2 mutant metastatic breast cancer
  • Finding pain relief in the kitchen
  • The 10th Annual Research Symposium of the Michael E. DeBakey Department of Surgery
  • All about autoimmune diseases

Baylor College of Medicine Blog Network

Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Dipali Pathak
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu

Jelmyto

From The Labs 

Playing with the physics of gels leads to a better kidney cancer treatment

May 14, 2020May 21, 2020cancer treatment, FDA approved, Jelmyto, kidney cancer, mitomycin, Research, UGN-101, Urothelial cancer

Effectively treating upper tract urothelial cancer – a cancer of the lining of the kidney or the ureter, the long, thin tube that connects that

Read more

From the Labs Image of the Month

From The Labs Image of the Month From the Labs: A selection of From the Labs Images of the Month on display in the A Hallway at Main Baylor.

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2020 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951